J. Willis

发表

The hemostatic system in children undergoing intensive plasma exchange.

P. Walsh, L. Brown, W. Grover, 1982, The Journal of pediatrics.

2-adrenergic receptor defect adenylate cyclase by epinephrine. Studies of a familial platelet alpha Differential requirements for platelet aggregation and inhibition of

R. Colman, M. Kowalska, A. Rao, 2011 .

Differential requirements for platelet aggregation and inhibition of adenylate cyclase by epinephrine. Studies of a familial platelet alpha 2-adrenergic receptor defect.

R. Colman, M. Kowalska, A. Rao, 1988, Blood.

Differential requirements for platelet aggregation and inhibition of adenylate cyclase by epinephrine. Studies of a familial platelet alpha 2-adrenergic receptor defect

R. Colman, M. Kowalska, A. Rao, 1988 .

Inhibition of platelet function by contrast media: iopamidol and ioxaglate versus iothalamate. Work in progress.

R. Steiner, V. Rao, A. Rao, 1985, Radiology.

Platelet secretion defect associated with impaired liberation of arachidonic acid and normal myosin light chain phosphorylation.

H. Holmsen, A. Rao, J. Smith, 1984, Blood.

Platelet‐activating factor is a weak platelet agonist: Evidence from normal human platelets and platelets with congenital secretion defects

C. Dangelmaier, H. Holmsen, A. Rao, 1984, American journal of hematology.

A major role of ADP in thromboxane transfer experiments: studies in patients with platelet secretion defects.

H. Holmsen, A. Rao, J. Willis, 1984, The Journal of laboratory and clinical medicine.

Comparative antithrombotic activities of the phosphodiesterase inhibitors pelrinone (AY-26,768), AY-31,390 and milrinone.

T. Colatsky, D. Patelunas, R. Fenichel, 1991, Thrombosis research.

Comparison of Antiplatelet Aggregatory and Antithrombotic Activity of Low Molecular Weight RD Heparin with Heparin

R. Fenichel, J. Willis, B. Small, 1989 .